Portfolio company
Hoba Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotech company develops therapeutic proteins and non-opioid compounds to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hoba Therapeutics ApS
This biotech company develops therapeutic proteins to treat patients suffering from chronic neuropathic pain and sensorineural hearing loss.
HDAX Therapeutics
This biotechnology company develops small molecule inhibitors targeting the HDAC6 protein to treat patients with neuropathies, heart failure and various cancer conditions.
Synerkine Pharma
This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.
Pheno Therapeutics
This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.
Decibel Therapeutics
This biotechnology company develops gene therapies to restore hearing and balance for patients with congenital hearing loss and related genetic disorders.
NovaGo Therapeutics
This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.
Nilo Therapeuti
This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
